Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008

Drug Resistance

Free Subscription Articles published in J Virol Retrieve available abstracts of 55 articles: HTML format

Single Articles

May 2008
1. DE PALMA AM , Heggermont W, Lanke K, Coutard B, et al
   The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C.
   J Virol. 2008;82:4720-30.
   PubMed     Related articles    Abstract available
   
   
   April 2008
2. YANG F , Robotham JM, Nelson HB, Irsigler A, et al
   Cyclophilin A is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine A Resistance In Vitro.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   March 2008
3. LITTLE SJ , Frost SD, Wong JK, Smith DM, et al
   The Persistence of Transmitted Drug Resistance among Subjects with Primary HIV Infection.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
4. HACHIYA A , Kodama EN, Sarafianos SG, Schuckmann MM, et al
   Amino Acid Mutation N348I in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Multi-class Resistance to Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitors.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   December 2007
5. GRAY ES , Moore PL, Bibollet-Ruche F, Li H, et al
   4E10 Resistant Variants in an HIV-1 Subtype C Infected Individual with an Anti-MPER Neutralizing Antibody Response.
   J Virol. 2007;.
   PubMed     Related articles    Abstract available
   
   
   November 2007
6. WATHELET MG , Orr M, Frieman MB, Baric RS, et al
   Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain.
   J Virol. 2007;81:11620-33.
   PubMed     Related articles    Abstract available
   
   
   October 2007
7. SHIMURA K , Kodama E, Sakagami Y, Matsuzaki Y, et al
   Broad Anti-Retroviral Activity and Resistance Profile of a Novel Human Immunodeficiency Virus Integrase Inhibitor, Elvitegravir (JTK-303/GS-9137).
   J Virol. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
8. CHOU S , Marousek GI
   Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.
   J Virol. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
9. ADAMIAK B , Ekblad M, Bergstrom T, Ferro V, et al
   Herpes Simplex Virus Type 2 Glycoprotein G is Targeted by the Sulfated Oligo- and Polysaccharide Inhibitors of the Virus Attachment to Cells.
   J Virol. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
10. DENG L , Dai P, Ciro A, Smee DF, et al
    Identification of novel antipoxviral agents: Mitoxantrone inhibits vaccinia virus replication by blocking virion assembly.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
11. DIERYNCK I , De Wit M, Gustin E, Keuleers I, et al
    Binding kinetics of darunavir to HIV-1 protease explain the potent antiviral activity and high genetic barrier.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
12. POON AF , Kosakovsky Pond SL, Richman DD, Frost SD, et al
    Mapping protease inhibitor resistance to HIV-1 sequence polymorphisms within patients.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
13. YEN HL , Ilyushina NA, Salomon R, Hoffmann E, et al
    Neuraminidase Inhibitor Resistant Recombinant A/Vietnam/1203/04 (H5N1) Influenza Viruses Retain Their Replication Efficiency and Pathogenicity in Vitro and in Vivo.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
14. AMBROSE Z , Palmer S, Boltz VF, Kearney M, et al
    Suppression of Viremia and Evolution of HIV-1 Drug Resistance in a Macaque Model for Antiretroviral Therapy.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
15. BROCKMAN MA , Schneidewind A, Lahaie M, Schmidt A, et al
    Escape and compensation from early HLA-B57-mediated CTL pressure on HIV-1 Gag alters capsid interactions with cyclophilin A.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
16. MEHANDRU S , Vcelar B, Wrin T, Stiegler G, et al
    Adjunctive passive immunotherapy in HIV-1-infected individuals treated with antiviral therapy during acute/early infection.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
17. CECCHERINI-SILBERSTEIN F , Svicher V, Sing T, Artese A, et al
    Characterization and Structural Analysis of Novel Mutations in HIV-1 Reverse Transcriptase Involved in the Regulation of Resistance to Non-Nucleoside Inhibitors.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
18. BUONAGURO L , Tornesello ML, Buonaguro FM
    HIV-1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
19. LIN G , Bertolotti-Ciarlet A, Haggarty B, Romano J, et al
    Replication competent variants of human immunodeficiency virus type-2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
20. WANG K , Mahalingam G, Hoover SE, Mont EK, et al
    Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.
    J Virol. 2007;81:6817-26.
    PubMed     Related articles    Abstract available
    
    
    June 2007
21. MANRIQUE A , Rusert P, Joos B, Fischer M, et al
    In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5 and 4E10.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
22. HAN JQ , Townsend HL, Jha BK, Paranjape JM, et al
    A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.
    J Virol. 2007;81:5561-72.
    PubMed     Related articles    Abstract available
    
    
    May 2007
23. KLEI HE , Kish K, Lin PF, Guo Q, et al
    X-ray Crystal Structures of HIV-1 Protease Mutants Complexed with Atazanavir.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. BESECKER MI , Furness CL, Coen DM, Griffiths A, et al
    Expression of Extremely Low Levels of Thymidine Kinase from an Acyclovir-Resistant Herpes Simplex Virus Mutant Support Reactivation from Latently Infected Mouse Trigeminal Ganglia.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
25. LOBRITZ MA , Marozsan AJ, Troyer RM, Arts EJ, et al
    Natural Variation in the V3 Crown of Human Immunodeficiency Virus Type 1 Affects Replicative Fitness and Entry Inhibitor Sensitivity.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. BREHM JH , Koontz D, Meteer JD, Pathak V, et al
    Selection of Mutations in the Connection and RNase H Domains of Human Immunodeficiency Virus Type 1 Reverse Transcriptase that Increase Resistance to 3'-Azido-3'-Dideoxythymidine.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. NORA T , Charpentier C, Tenaillon O, Hoede C, et al
    Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral Treatment.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
28. CHINNADURAI R , Rajan D, Munch J, Kirchhoff F, et al
    HIV-1 Variants Resistant against 1st and 2nd Generation Fusion Inhibitors and Cytopathic in ex vivo Human Lymphoid Tissue.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
29. DELVIKS-FRANKENBERRY KA , Nikolenko GN, Barr R, Pathak VK, et al
    Mutations in Human Immunodeficiency Virus Type-1 RNase H Primer Grip Enhance 3'-Azido-3'-Deoxythymidine Resistance.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
30. LI J , Chorba JS, Whelan SP
    Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.
    J Virol. 2007;81:4104-15.
    PubMed     Related articles    Abstract available
    
    
    March 2007
31. ROBIDA JM , Nelson HB, Liu Z, Tang H, et al
    Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine A In Vitro.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
32. MUZAMMIL S , Armstrong AA, Kang LW, Jakalian A, et al
    Unique Thermodynamic Response of Tipranavir to HIV-1 Protease Drug Resistance Mutations.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. MULLER S , Moller P, Bick MJ, Wurr S, et al
    Inhibition of filovirus replication by the zinc finger antiviral protein.
    J Virol. 2007;81:2391-400.
    PubMed     Related articles    Abstract available
    
    
    February 2007
34. HELD DM , Kissel JD, Thacker SJ, Michalowski D, et al
    Cross-clade inhibition of recombinant HIV-1, HIV-2 and SIVcpz reverse transcriptases by RNA pseudoknot aptamers.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. PEREZ-BERCOFF D , Wurtzer S, Compain S, Benech H, et al
    HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 RESISTANCE TO NUCLEOSIDE ANALOGUES AND REPLICATIVE CAPACITY IN PRIMARY HUMAN MACROPHAGES.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
36. SIERRA M , Airaksinen A, Gonzalez-Lopez C, Agudo R, et al
    Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe.
    J Virol. 2007;81:2012-24.
    PubMed     Related articles    Abstract available
    
    
    January 2007
37. YANG R , Aiken C
    A Mutation in Alpha Helix 3 of CA Renders Human Immunodeficiency Virus Type 1 Cyclosporin A-Resistant and Dependent: Rescue by a Second-Site Substitution in a Distal Region of CA.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. RAY N , Harrison JE, Blackburn LA, Martin JN, et al
    Clinical resistance to enfuvirtide does not affect susceptibility to other classes of entry inhibitors.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. HEIPERTZ RA JR , Miller TG, Kelley CM, Delaney WE 4th, et al
    In Vitro Study of the Effects of Precore and Lamivudine Resistant Mutations on HBV Replication.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
40. MUELLER SM , Schaetz B, Eismann K, Bergmann S, et al
    Dual selection pressure by drugs and HLA class I-restricted immune responses on HIV-1 protease.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    December 2006
41. CONG ME , Heneine W, Garcia-Lerma JG
    Mutational interactions modulate the fitness cost of drug-resistant HIV-1.
    J Virol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
42. WESTBY M , Smith-Burchnell C, Mori J, Lewis M, et al
    Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry.
    J Virol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    October 2006
43. CHRISTEN V , Duong F, Bernsmeier C, Sun D, et al
    Inhibition of Interferon alpha Signaling by Hepatitis B Virus.
    J Virol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
44. BALZARINI J , Van Laethem K, Daelemans D, Hatse S, et al
    PRADIMICIN A: A CARBOHYDRATE-BINDING NON-PEPTIDIC LEAD COMPOUND FOR TREATMENT OF VIRUS INFECTIONS WITH A HIGHLY GLYCOSYLATED ENVELOPE SUCH AS THE HUMAN IMMUNODEFICIENCY VIRUS.
    J Virol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
45. ZHOU J , Chen CH, Aiken C
    HIV-1 Resistance to the Small Molecule Maturation Inhibitor 3-O-{3',3'-dimethylsuccinyl}-betulinic acid is Conferred by a Variety of Single Amino Acid Substitutions at the CA-SP1 Cleavage Site in Gag.
    J Virol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
46. ALFF PJ , Gavrilovskaya IN, Gorbunova E, Endriss K, et al
    The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses.
    J Virol. 2006;80:9676-86.
    PubMed     Related articles    Abstract available
    
    
    
47. ANDREI G , Gammon DB, Fiten P, De Clercq E, et al
    Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice.
    J Virol. 2006;80:9391-401.
    PubMed     Related articles    Abstract available
    
    
    September 2006
48. ADAMSON CS , Ablan SD, Boeras I, Goila-Gaur R, et al
    IN VITRO RESISTANCE TO THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 MATURATION INHIBITOR PA-457 (BEVIRIMAT).
    J Virol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
49. LUBAN J
    Cyclophilin A, TRIM5, and Resistance to HIV-1 Infection.
    J Virol. 2006;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
50. LABROSSE B , Morand-Joubert L, Goubard A, Rochas S, et al
    Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patients.
    J Virol. 2006;80:8807-19.
    PubMed     Related articles    Abstract available
    
    
    
51. YEN HL , Hoffmann E, Taylor G, Scholtissek C, et al
    Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses.
    J Virol. 2006;80:8787-95.
    PubMed     Related articles    Abstract available
    
    
    
52. BALZARINI J , Van Laethem K, Peumans WJ, Van Damme EJ, et al
    Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes.
    J Virol. 2006;80:8411-21.
    PubMed     Related articles    Abstract available
    
    
    August 2006
53. BAXTER JD , Schapiro JM, Boucher CA, Kohlbrenner VM, et al
    Genotypic Changes in Human Immunodeficiency Virus-1 Protease Associated with Reduced Susceptibility and Virologic Response to the Protease Inhibitor Tipranavir.
    J Virol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
54. OKAZAKI T , Terabe M, Catanzaro AT, Pendleton CD, et al
    Possible therapeutic vaccine strategy against HIV escape from RT inhibitor studied in HLA-A2 transgenic mice.
    J Virol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    January 2006
55. PAESHUYSE J , Leyssen P, Mabery E, Boddeker N, et al
    A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase.
    J Virol. 2006;80:149-60.
    PubMed     Related articles    Abstract available   Free Full Text
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: